First Clinical Trial for Huntington’s Disease Using Stem Cell Therapy Begins: What You Need to Know
A major update was shared at the ISSCR 2026 Annual Meeting about the first clinical trial testing a new treatment […]
New Hope for Boys with Duchenne Muscular Dystrophy: FDA Grants Special Status to Experimental Drug Tegacorat
Grünenthal, a pharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has given two special designations to
Pharmaceutical News
Pharmaceutical Company Lonza Expands Swiss Facility to Meet Rising Demand for Advanced Cancer Treatments
Lonza, a leading company in pharmaceutical manufacturing, is investing in its facility located in Visp, Switzerland, to meet the growing
New Psilocybin-Based Depression Treatment Shows Promising Results in Major Clinical Trial
A pharmaceutical company called Compass Pathways has shared positive six-month results from a large study testing a new depression treatment.
KQ Labs Opens Applications for Its Ninth Cohort to Support Early-Stage Health Startups
The Francis Crick Institute, in partnership with Medicines Discovery Catapult and Cancer Research Horizons, has opened applications for the ninth
UAE Launches Groundbreaking Study to Prevent Alzheimer’s Disease Using Genomics
A major healthcare initiative in the UAE has just begun a first-of-its-kind clinical trial that uses genetic testing to try
Pharmaceutical News
Pharmacy Expert Explains Key Trends in Capsule Development at Barcelona Conference
During the CPHI Barcelona conference in October, European Pharmaceutical Review spoke with Julien Lamps, an expert from Lonza CHI, about
Pharmaceutical News
New Simple Method for Making Diabetes Drugs Could Lower Costs and Boost Production
Scientists have developed a much simpler way to manufacture a key ingredient in some of the most popular type 2
Pharmaceutical News
Understanding the Challenges and Progress in Developing Better Pain Medications: A Pharmacist’s Perspective
In this interview, Torsten Madsen, CEO of Hoba Therapeutics, shares insights about the challenges and opportunities in developing new medications
Swedish Pharma Company AlzeCure Partners with Danish Biotech to Develop New Alzheimer’s and Brain Disease Treatment
AlzeCure Pharma, a Swedish pharmaceutical company, has signed a major deal with QuantumCell ApS, a Danish biotechnology company. This agreement